<?xml version='1.0' encoding='utf-8'?>
<document id="31002484"><sentence text="Clinically Significant Drug-Drug Interaction in a Large Antiretroviral Treatment Centre in Lagos, Nigeria." /><sentence text="Background: An important cause of treatment failure to antiretroviral therapy (ART) is the potential interaction between the antiretroviral (ARV) drugs and co-prescribed drugs used concomitantly for the treatment of opportunistic infections and co-morbid ailments in HIV-infected patients" /><sentence text=" Objectives: The study evaluated potential clinically significant drug interactions (CSDIs) occurring between recommended ART regimens and their co-prescribed non-antiretroviral drugs (CPD) Method: This study was carried out in a large HIV treatment centre (APIN clinic) in a Nigerian teaching hospital, in Lagos Nigeria, caring for over 20,000 registered patients" /><sentence text=" Electronic Medical Records (EMR) of 500 patients  who received treatment between 2005 and 2015, were selected using systematic random sampling, reviewed retrospectively, and evaluated for potential CSDIs using Liverpool HIV Pharmacology Database and other similar databases" /><sentence text="                                                                                                                                          Results:  Majority of patients, 421 (84%) were at risk of CSDIs, of  which  410, (82%) were moderate and frequently involved co-trimoxazole + zidovudine (or stavudine) /lamivudine (386, 77"><entity charOffset="295-304" id="DDI-PubMed.31002484.s5.e0" text="stavudine" /><entity charOffset="307-317" id="DDI-PubMed.31002484.s5.e1" text="lamivudine" /><pair ddi="false" e1="DDI-PubMed.31002484.s5.e0" e2="DDI-PubMed.31002484.s5.e0" /><pair ddi="false" e1="DDI-PubMed.31002484.s5.e0" e2="DDI-PubMed.31002484.s5.e1" /></sentence><sentence text="2%) and NNRTIs or PIs + artemisinin-based combination therapies (ACTs) [296, 59"><entity charOffset="24-35" id="DDI-PubMed.31002484.s6.e0" text="artemisinin" /></sentence><sentence text="2%]" /><sentence text=" Age (p=0" /><sentence text="131), sex (p=0" /><sentence text="316) and baseline CD4+ cell counts (p&gt;0" /><sentence text="05) were not significantly associated with CSDIs" /><sentence text=" The interactions, however, were significantly associated with the development of antiretroviral treatment failure (p &lt;0" /><sentence text="001) which occurred in nearly a third (139; 27" /><sentence text="8%) of the patients" /><sentence text=" Conclusion: There is a high prevalence of CSDIs between ART and CPDs most of which were categorized as moderate" /><sentence text="  Further studies are required to evaluate the pharmacokinetic and clinical relevance of these interactions" /><sentence text="" /></document>